a user-friendly procedure that analyses genomic, clinical and demographic data to generate a personalized report with statistical analysis on the efficacy of antidepressants and their side effects

Project Information

Predictix Antidepres

Grant agreement ID: 832230

DOI 10.3030/832230

Closed project

EC signature date 4 December 2018

Start date 1 November 2018

End date 28 February 2019

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

TALIAZ LTD
Israel